Literature DB >> 23943427

Differential sensitivity of the species of Candida parapsilosis sensu lato complex against statins.

Judit Szenzenstein1, Attila Gácser, Zsuzsanna Grózer, Zoltán Farkas, Katalin Nagy, Csaba Vágvölgyi, János Márki-Zay, Ilona Pfeiffer.   

Abstract

Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis are human fungal pathogens with clinical importance. The recently reclassified three closely related species have significant variation in virulence, clinical prevalence and susceptibility characteristics to different antifungal compounds. The aim of this study was to investigate the in vitro activity of atorvastatin and fluvastatin against C. metapsilosis, C. orthopsilosis and C. parapsilosis. Susceptibility tests showed that C. parapsilosis was the most sensitive while C. orthopsilosis was the least susceptible species to both drugs. On the basis of the differential sensitivity, we developed a simple, reliable and highly cost-effective plate assay to distinguish these closely related species. Applying this method, 54 isolates belonging to the C. parapsilosis sensu lato complex deposited in Szeged Microbial Collection could be sorted into the three species with 100 % probability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23943427     DOI: 10.1007/s11046-013-9689-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  11 in total

1.  Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.

Authors:  Jia L Song; Chris N Lyons; Scott Holleman; Brian G Oliver; Theodore C White
Journal:  Med Mycol       Date:  2003-10       Impact factor: 4.076

Review 2.  Statins: mechanism of action and effects.

Authors:  C Stancu; A Sima
Journal:  J Cell Mol Med       Date:  2001 Oct-Dec       Impact factor: 5.310

3.  A gift from nature: the birth of the statins.

Authors:  Akira Endo
Journal:  Nat Med       Date:  2008-10       Impact factor: 53.440

4.  Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary.

Authors:  Sándor Kocsubé; Mónika Tóth; Csaba Vágvölgyi; Ilona Dóczi; Miklós Pesti; István Pócsi; Judit Szabó; János Varga
Journal:  J Med Microbiol       Date:  2007-02       Impact factor: 2.472

5.  [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].

Authors:  G Thierry; F Morio; P Le Pape; F Gay-Andrieu; O Barre; M Miegeville
Journal:  Pathol Biol (Paris)       Date:  2010-09-15

6.  Growth inhibition of Candida species and Aspergillus fumigatus by statins.

Authors:  Ian G Macreadie; Georgia Johnson; Tanja Schlosser; Peter I Macreadie
Journal:  FEMS Microbiol Lett       Date:  2006-09       Impact factor: 2.742

7.  Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans.

Authors:  James D Nash; David S Burgess; Robert L Talbert
Journal:  J Med Microbiol       Date:  2002-02       Impact factor: 2.472

8.  Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Authors:  Arianna Tavanti; Amanda D Davidson; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 9.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 10.  Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.

Authors:  Eveline C van Asbeck; Karl V Clemons; David A Stevens
Journal:  Crit Rev Microbiol       Date:  2009       Impact factor: 7.624

View more
  2 in total

1.  Genome comparison of Candida orthopsilosis clinical strains reveals the existence of hybrids between two distinct subspecies.

Authors:  Leszek P Pryszcz; Tibor Németh; Attila Gácser; Toni Gabaldón
Journal:  Genome Biol Evol       Date:  2014-05       Impact factor: 3.416

2.  Members of the Candida parapsilosis Complex and Candida albicans are Differentially Recognized by Human Peripheral Blood Mononuclear Cells.

Authors:  Eine Estrada-Mata; María J Navarro-Arias; Luis A Pérez-García; Erika Mellado-Mojica; Mercedes G López; Katalin Csonka; Attila Gacser; Héctor M Mora-Montes
Journal:  Front Microbiol       Date:  2016-01-13       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.